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that we unravel how these risk factors interact within and between 
the diverse cell types populating the brain. While mouse models are 
uniquely suited for demonstrating how aberrant function of  single gene 
products contribute to aberrant neuronal function or behavior, genetic 
studies of  penetrance and complex gene interactions are nearly impos-
sible to address using inbred mouse lines. Similarly, the lack of  human 
post-mortem tissue, coupled with the inability to conduct functional 
experiments in patient cells, has to date left us with a very limited under-
standing of  how rare and common variants impact gene expression or 
cellular function. Our panelists have each developed human induced 
pluripotent stem cell (hiPSC)-based models for the study of  predispo-
sition to neuropsychiatric disease, establishing a new mechanism by 
which to systematically explore the impact of  rare and common putative 
causal variants in human cells.
Given the heterogeneity of schizophrenia and the limited cohort sizes fea-
sible with hiPSC-based cohorts, our panelists will share their successes and 
struggles in developing cohorts defined by shared clinical or genetic fea-
tures. They will discuss both the molecular and phenotypic insights they 
have uncovered, in neurons and glia, from case/control and genetically-
edited isogenic cohorts. Our discussant will focus on integrating these 
findings into consortia-led datasets generated from recent genomic and 
post-mortem studies of large schizophrenia cohorts. Our overall objective 
is to consider the role of hiPSC-based studies in dissecting the genetic ori-
gins of schizophrenia, validating causal variants identified through ongoing 
genetic analyses, and serving as a personalized medicine approach to screen 
for novel therapeutics with which to prevent or reverse disease course.
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Background: Reciprocal genomic disorders (RGDs) represent a unique class 
of recurrent genomic variation that offer insight into highly dosage sensitive 
regions of the morbid human genome. However, the genomic architecture 
mediating RGDs, namely non-allelic homologous recombination (NAHR) 
of flanking segmental duplications, has rendered these genomic segments 
recalcitrant to conventional model studies. We recently developed a novel 
CRISPR method that leverages the homology of segmental duplications 
and efficiently generates large microdeletions and microduplications that 
mimic NAHR in humans, including ablation or duplication of one copy 
equivalent of the segmental duplications. Here, we explore the functional 
consequences of 16p11.2 RGD in iPS derived neuronal models and across 
mouse tissues.
Methods: We generated CRISPR-engineered 16p11.2 RGD models 
against an isogenic iPSC background and performed transcriptome pro-
filing in iPSC-derived neural stem cells (NSCs) and induced neurons 
(iN) (n  =  10 isogenic deletions, 10 duplications, 6 controls). We then 
integrated these data with RNAseq from 306 libraries from multiple 
tissues in 70 mouse models of  reciprocal deletion and duplication of 
the syntenic 7qf3 region (cortex, striatum, cerebellum, liver, white fat, 
brown fat in 16 mice; and replication from cortex, striatum, cerebellum 
in 54 mice).
Results: In ongoing analyses, weighted-gene correlation network analy-
sis (WGCNA) identified co-expression modules that were significantly 
enriched for 16p11.2 genes, evolutionarily constrained genes, genes robustly 
associated with autism spectrum disorder (ASD; TADA q < 0.1) and devel-
opmental disorders (DDD). Pathway analyses within modules discovered 
enrichment of genes critical to synaptic formation and neural connectiv-
ity as well as the protocadherin gene family. Network analyses specific to 
brain tissues within modules further identified a convergence on highly con-
nected, or ‘hub’ genes, on Wnt signaling, including Ctnnb1 and Ctnnd1. 
The module was also again enriched for ASD loci (TADA, FDR < 0.1), 
constrained genes (ExAC, pLI ≥ 0.9) and brain specific genes from the 
Human Protein Atlas.
Discussion: These studies suggest the functional consequences of 
16p11.2 RGD across models converge on transcriptional signatures 
associated with critical neurodevelopmental pathways and individual 
genes implicated in a spectrum of  developmental and neuropsychiatric 
disorders.
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Background: Several large copy number variants (CNVs) in the geno-
mic sequence are strongly associated with schizophrenia. These loci are 
important objects of  study in their own right as well as enticing points 
of  entry for the better understanding of  the molecular etiology of  schiz-
ophrenia. However, most of  the schizophrenia-associated large CNVs 
are larger than one million base pairs and affect up to several dozen 
genes, presenting a complex challenge for research aiming to determine 
how these sequence variants are connected on the molecular level to the 
phenotype.
Methods: We have established iPSC based tissue culture models for three 
of  the major schizophrenia associated large CNVs, on chromosomes 
22q11 (deletion), 15q13 (deletion) and 16p11 (deletion or duplication). 
We create neuronal cells with the defined genotypes using either direct 
induction into the neuronal state (induced neurons, iNs), by slower dif-
ferentiation via neuronal precursor cells (NPCs) or by generating 3D cul-
tures of  cortical spheroids. We then assay the molecular effects of  the 
large CNVs along the trajectory of  differentiation by using RNA-Seq 
(transcriptome), ATAC-Seq (chromatin state) and SeqCap-Epi (DNA-
methylation patterns). We also carry out single-cell RNA-Seq analysis 
using the drop-Seq approach.
Results: We detect common effects across the large CNVs as well as 
locus-specific phenomena. For the most part genes within the CNV 
boundaries will change their expression patterns in concordance with 
their new copy number, with notable exceptions. Transcriptome-wide 
there is a network effect where several hundred genes are differentially 
expressed, including genes already identified as candidate genes for 
schizophrenia. Epigenomic states are affected, again most often not 
only in or nearby the boundaries of  the large CNVs but epigenome-
wide. Integrative analysis across the layers of  molecular signals shows 
partial concordance as well as a degree of  changes in signal being 
‘offset’ between the levels, potentially owing to the dynamic differen-
tiation state of  the model system.
Discussion: Neuronal tissue culture models based on iPSCs with defined 
large CNVs strongly associated with Schizophrenia allow for an anal-
ysis of  the effects of  such structural genomic sequence changes in dis-
ease-relevant cellular differentiation states. Application of  cutting edge 
genomics and epigenomics assays and integrative data analysis reveals 
incomplete transcriptional dosage compensation of  the genes within the 
large CNVs as well as transcriptome-wide network effects. Furthermore, 
there are epigenomic effects in the form of  altered chromatin states that 
may to some extent mediate the gene expression changes. Differences 
between the large CNV loci as well as potential points of  convergence 
will be discussed.
